Indrayani Biotech Stock Screener | Share Price & Fundamental Analysis
INDRANIB
Agricultural Products
Screen Indrayani Biotech share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹11.19
▼
-0.17 (-1.50%)
Market Cap
₹61.60 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
0.81
EPS (TTM)
₹-1.35
Dividend Yield
-
Debt to Equity
1.49
52W High
₹34.84
52W Low
₹11.19
Operating Margin
-6.00%
Profit Margin
-16.98%
Revenue (TTM)
₹53.00
EBITDA
-
Net Income
₹-9.00
Total Assets
₹268.00
Total Equity
₹73.00
Indrayani Biotech Share Price History - Stock Screener Chart
Screen INDRANIB historical share price movements with interactive charts. Analyze price trends and patterns.
Indrayani Biotech Company Profile - Fundamental Screener
Screen Indrayani Biotech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for INDRANIB shares.
Sector
FMCG
Industry
Agricultural Products
Sub-Sector
Agricultural Products
Segment
E
ISIN
INE007C01021
Indrayani Biotech Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen INDRANIB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 268 | 235 | 156 | 51 | 40 | 52 |
| Current Assets | 178 | 145 | 78 | 19 | 9 | 19 |
| Fixed Assets | 60 | 62 | 58 | 17 | 15 | 17 |
| Liabilities | ||||||
| Total Liabilities | 268 | 235 | 156 | 51 | 40 | 52 |
| Current Liabilities | 66 | 72 | 36 | 7 | 8 | 7 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||
| Total Equity | 73 | 76 | 48 | 25 | 20 | 31 |
| Share Capital | 46 | 46 | 44 | 34 | 34 | 4 |
| Reserves & Surplus | 27 | 18 | 10 | -10 | -15 | -3 |
Screen INDRANIB income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 53 | 30 | 38 | 45 | 32 | 31 | 17 | 51 | 42 | 41 | 39 | 17 | 26 | 44 | 46 |
| Expenses | 54 | 27 | 34 | 34 | 26 | 26 | 14 | 46 | 40 | 33 | 36 | 15 | 23 | 37 | 41 |
| EBITDA | 0 | 3 | 4 | 11 | 6 | 5 | 3 | 5 | 3 | 7 | 4 | 2 | 3 | 7 | 5 |
| Operating Profit % | -6.00% | 7.00% | 7.00% | 23.00% | 19.00% | 17.00% | 17.00% | 6.00% | 6.00% | 18.00% | 9.00% | 13.00% | 12.00% | 12.00% | 12.00% |
| Depreciation | 10 | 1 | 1 | 1 | 4 | 3 | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
| Interest | -2 | 2 | 2 | 6 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 0 | 1 | 1 | 1 |
| Profit Before Tax | -8 | 0 | 1 | 5 | 1 | 1 | 0 | 2 | 0 | 6 | 1 | 2 | 2 | 5 | 3 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -9 | 0 | 1 | 5 | 1 | 1 | 0 | 1 | 0 | 6 | 1 | 2 | 2 | 5 | 3 |
| EPS | -1.42 | 0.03 | 0.09 | 0.58 | 0.10 | 0.13 | 0.05 | 0.32 | -0.06 | 0.89 | 0.22 | 0.47 | 0.52 | 1.47 | 0.72 |
Indrayani Biotech Cash Flow Screener - Liquidity Fundamentals
Screen INDRANIB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|
| Operating Activities | -30 | 16 | 4 | 0 | 6 |
| Investing Activities | -16 | -47 | -1 | -1 | -4 |
| Financing Activities | 44 | 33 | -3 | 0 | -1 |
| Net Cash Flow | -3 | 2 | 1 | -1 | 1 |
Screen INDRANIB shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Apr | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 33.26% | 33.28% | 33.28% | 33.28% | 33.40% | 33.48% | 33.57% | 42.13% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 3.13% | 3.11% | 3.66% | 5.25% | 5.59% | 6.79% | 6.75% | 8.47% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 48.08% | 47.32% | 46.64% | 46.37% | 45.86% | 43.63% | 55.78% | 44.33% |
| Other Holding | 15.53% | 16.29% | 16.42% | 15.10% | 15.16% | 16.09% | 3.90% | 5.07% |
| Shareholder Count | 25,686 | 25,704 | 25,126 | 25,254 | 24,419 | 24,132 | 23,958 | 23,914 |
Indrayani Biotech Dividend Screener - Share Yield Analysis
Screen INDRANIB dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Indrayani Biotech Index Membership - Market Screener Classification
Screen INDRANIB by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Indrayani Biotech Market Events Screener - Corporate Actions
Screen INDRANIB market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 9.84% | ||
| 2025-12-11 | 2025-12-11 | Quarterly Result Announcement | NA | -0.43% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -1.99% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | -5.05% |
| 2025-06-13 | 2025-06-13 | Quarterly Result Announcement | NA | -6.75% |
| 2025-02-27 | 2025-02-27 | Quarterly Result Announcement | NA | -19.84% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -6.59% |
| 2024-08-22 | 2024-08-22 | Annual General Meeting | NA | -10.28% |
Indrayani Biotech Competitors Screener - Peer Comparison
Screen INDRANIB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| LT Foods | 14,039 | 21.97 | 8,770 | 12.12% | 612 | 52.67 |
| KRBL | 9,035 | 14.83 | 5,655 | 3.17% | 476 | 49.73 |
| Gujarat Ambuja Exports | 5,610 | 27.16 | 4,695 | -7.42% | 249 | 64.19 |
| Kaveri Seed Company | 4,999 | 16.52 | 1,251 | 3.28% | 282 | 47.10 |
| Trualt Bioenergy | 3,470 | 22.60 | 1,969 | 53.77% | 147 | 40.08 |
| GRM Overseas | 2,969 | 43.79 | 1,374 | 2.17% | 61 | 65.63 |
| Sanstar | 1,656 | 24.84 | 1,082 | -10.58% | 67 | 49.04 |
| Chaman Lal Setia Exports | 1,299 | 13.86 | 1,504 | 10.16% | 103 | 48.65 |
| Bombay Super Hybrid Seeds | 1,077 | 38.88 | 362 | 40.17% | 26 | 42.58 |
| Avt Natural Products | 1,006 | 16.38 | 572 | 8.00% | 48 | 41.71 |
Indrayani Biotech Company Announcements - News Screener
Screen INDRANIB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-03 | Results For Unaudited Fnancial Results For Quarter And Half Year Ended September 2025 | View |
| 2026-01-01 | Intimation Of Fine Levied By BSE | View |
| 2025-12-30 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-12-30 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-12-11 | Results - For The Quarter Ended 30Th September 2025 | View |
| 2025-12-11 | Results - For The Quarter Ended 30Th September 2025 | View |
| 2025-12-11 | Board Meeting Outcome for Outcome Of Board Meeting Held On 11Th December 2025 For Approval Of Unaudited (Consolidated And Standalone) Financial Results For The Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-12-05 | Board Meeting Intimation for Adoption Of Unaudited Financial (Standalone And Consolidated) Results For The Quarter And Half Year 30Th September 2025 | View |
| 2025-11-14 | Board Meeting Outcome for Board Meeting Outcome For Adoption Of Unaudited Standalone And Consolidated Financial Results For The Quarter Half Year Ended September 2025 | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-11-13 | Board Meeting Intimation for Approval Of Unaudited Financial (Standalone And Consolidated) Results For The Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-11-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-01 | Resolutions Passed In The 33Rd AGM | View |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-27 | Appointment of Company Secretary and Compliance Officer | View |
| 2025-09-24 | Closure of Trading Window | View |
| 2025-09-20 | Receipt Of In-Priniciple Approval | View |
| 2025-09-16 | Announcement Under Regulation 30 Of SEBI LODR With Regard To Approval Of Category II AIF | View |